mini banner EAOM2021 01 01

Provisional Program Overview

Provisional schedule, order of presentation and lecture titles

  • DAY 1 (FRIDAY, 24TH SEPTEMBER)

    Time Topic - ROOM 1 Topic - ROOM 2
    08h00 - 08h15 Congress Opening  
    08h15 - 09h00 “Crispian Scully Lecture” by Peter A. Brennan (UK)
     • Human factors - the art of applying common sense at work when treating oral cancer
     
    09h00 - 13h00

    09h00 - 13h00
    OPMD and oral cancer
     • 09h00 - The public health program for oral cancer detection in Portugal – Pedro Trancoso (Portugal)
     • 09h25 - Screening for OPMDs and oral cancer – Giovanni Lodi (Italy)
     • 09h50 - Adjunctiv tools in the diagnosis of OPMD with a focus on contact endoscopy – Luis Monteiro (Portugal)
     • 10h15 - Risk stratification of oral leukoplakia – Samam Warnakulasuriya (UK)

     10h40 - 11h00: Break

     • 11h00 - Diagnostic considerations for patients with Leukoplakia – Ross Kerr (USA)
     • 11h25 - Oral lichen planus as an oral potentially malignant disorder – Miguel Gonzales Moles (Spain)
     • 11h00 - Sentinel lymph node biopsy in the management of oral cancer – Abel Garcia (Spain)
    12h15 - Discussion


    09h00 - 10h40
    Medically compromised patients. New insights in...
     • 09h00 - ...dental management of solid organ transplant patients – Jukka Meurman (Finland)
     • 09h25 - ...dental management of patients with head and neck cancer – Marcio Diniz-Freitas (Spain)
     • 09h50 - ...oral features of rheumatic diseases – from disease activity to drug adverse events – Luis Gueiros (Brazil)
     • 10h15 - In progress

     10h40 - 11h00: Break

    11h00 -
    13h00
    8 Oral Presentations (research)
    10 min presentation + 5 min of questions




    13h00 Break Break
    14h00 - 17h00

    Immune mediated oral diseases
     • 14h00 - Immunobiologic therapy for MMP – Michele Mignogna (Italy)
     • 14h25 - Immunobiologic therapy for PV– Jane Setterfield (UK)
     • 14h50 - Oral microbiome and immune-mediated oral diseases : Aphtous stomatitis – Karolin Hijazi (UK)

     15h15 - 15h45: Break

     • 15h45 - Microbiome in Sjogren's syndrome – Arjan Vissink ( the Netherlands)
     • 16h10 - Current concepts in the topical treatment of OLP – Nathaniel Treister (USA)
     • 16h35 - Current concepts in the systemic treatment of OLP – Marco Carrozzo (UK)
     • 17h00 - Discussion

    8 Oral Presentations (clinical)
    10 min presentation + 5 min of questions

     

     

     15h15 - 15h45: Break

     

     

     

    Time Topic - ROOM 3 Topic - ROOM 4
    24h/24h

    Oral Presentations (Research and Clinical) 24h/24h

    Poster Presentations 24h/24h

  • DAY 2 (SATURDAY, 25TH SEPTEMBER)

    Time Topic - ROOM 1 Topic - ROOM 2
    08:00 h. - 11:00 h.

    08h00 - 11h00.
    Molecular aspects of oral leucoplakia and their influence on its diagnosis and management
     • 08h00 - Prognostic biomarkers of oral leukoplakia: evidence and outcomes from systematic reviews. - Antonio Celentano (Australia)
     • 08h25 - Correlation between molecular markers and histopathological features of oral leukoplakia.
    Nikos Nikitakis (Greece)
     • 08h50 - Diagnostic microRNA profile of oral leukoplakia. - Tami Yap (Australia)
     • 09h15 - Molecular biomarkers of malignant transformation in oral leukoplakia. - Michael McCullough (Australia)
     • 09h40 - Salivary metabolomics and oral leukoplakia. - Marco Meleti (Italy)
     • 10h05 - Exomic and transcriptomic profile of oral leukoplakia; have we arrived at a paradigm shift? - Camile Farah (Australia)

    08h00 - 10h45.
    Clinico-Pathological Session
    Contributor only (20 min incl. discussion/voting)
    8 Cases in total

     

     


    10:45 h. - 11:00 h. Break Break
    11:00 h. - 13:00 h. General Assembly of the EAOM Room closed
    13:00 h. - 14:00 h. Lunch Lunch
    14:00h. - 17:00 h.

    14h00 - 15h15
    European Cooperation Clinical Research
     • 14:00h - Multicentre Clinical studies: the good, the bad and the ugly – Stefano Fedele (UK)
     • 14:25h - The design, funding, setting-up and delivery of Pan-European collaborative research – Andy Wolff (Israel)
     • 14:50h - Global clinical trials in Oral Medicine: how it is done by the Industry. Lars Siim Madsen, Chief Operating Officer, Afyx Therapeutics.
     • 15:15h - Discussion

     15:15 h - 15h45: Break

    15h45 - 17h00
    Global cooperation in oral medicine
     • In progress

    14h00 - 15h15
    Systemic diseases and the mouth
     • 14:00h - Oral manifestations of systemic diseases – Stephen Porter (UK)
     • 14:25h - Oral side effects of various systemic medications – Michael Escudier
     • 14:50h - In progress

     15:15 h - 15h45: Break

     • 15:45h - Medication-related osteonecrosis of the jaws – Paolo Vescovi (Italy)
     • 16:10h - Oral Manifestations of Covid 19 – in progress
     • 16:35h - Discussion

    17:00 h. - 17:15 h. Next EAOM meeting presentation  
    17:15 h. Closing of the Congress  
    Time Oral Presentations - ROOM 3 Posters - ROOM 4
    24 h/24 h.

    Oral Presentations (Research and Clinical) 24h/24 hours

    Poster Sessions 24h/24 hours

  • 1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Organization

eaom logo

Abreu Events

Professional Congress Organizer
This email address is being protected from spambots. You need JavaScript enabled to view it.
+351 965 101 393
Praça da Trindade, 142, 4º, 4000-539
Porto, Portugal